Vancouver, British Columbia–(Newsfile Corp. – May 11, 2021) – Amphotericin B Technologies, Inc (“Amp B Tech” or the “Company”), a wholly-owned subsidiary of iCo Therapeutics, Inc. (TSXV: ICO) (“iCo”), announced… Read More
THOUSAND OAKS, Calif., May 10, 2021 —Amgen (NASDAQ: AMGN) today announced its partner AstraZeneca (NASDAQ: AZN) submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA)… Read More
In the mid-1970s, immunologist Stuart Schlossman had a lab space problem. In order to unravel the ins and outs of T cell biology, he was working with a then-new and… Read More
Overview of the Program With the establishment of Lumira Ventures Fund IV, the largest life sciences focused venture fund ever raised in Canada, we are launching our Lumira Ventures Venture… Read More
Vancouver, BC and INNSBRUCK, Austria – May 6, 2021 – AbCellera (Nasdaq: ABCL) and Angios GmbH (Angios) announced today that they have entered into a multi-year, multi-target collaboration to facilitate… Read More
